Search Results
Jul 31, 2026, 14:41 ET ADMA AUGUST 10, 2026 DEADLINE: ADMA Biologics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit- HBSS
844-916-0895Alleged Wrongdoing in ADMA Biologics Lawsuit: The lawsuit alleges that Defendants artificially inflated stock value by misrepresenting and failing to disclose that:ADMA Biologics engaged in an undisclosed related party transaction;ADMA Biologics used
More news about: Hagens Berman Sobol Shapiro LLP
Jul 31, 2026, 03:55 ET ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with SBS Law
action lawsuit against ADMA Biologics, Inc. ("ADMA" or "the Company") (NASDAQ: ADMA) for violations of
More news about: Schall, Brown & Schwartz LLP
Jul 31, 2026, 02:52 ET ADMA Biologics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ADMA
action lawsuit against ADMA Biologics, Inc. ("ADMA" or "the Company") (NASDAQ: ADMA) for violations of
More news about: DJS Law Group LLP
Jul 30, 2026, 10:07 ET SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 10, 2026 in ADMA BIOLOGICS, INC. Lawsuit - ADMA
securities litigation firms in the United States.Frequently Asked Questions About the ADMA LawsuitQ: Who are the defendants named in the ADMA lawsuit? A: The complaint names ADMA Biologics, Inc. and individual defendants including CEO Adam S. Grossman, Vice Chairman Jerrold
More news about: SueWallSt.com
Jul 29, 2026, 22:56 ET ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
action lawsuit against ADMA Biologics, Inc. ("ADMA" or the "Company")(NASDAQ: ADMA).
More news about: Glancy Prongay Wolke & Rotter LLP
Jul 29, 2026, 13:47 ET ADMA INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- HBSS
undisclosed related party transaction;ADMA Biologics used channel stuffing to create an appearance of revenue;ADMA Biologics lacked adequate internal controls; andAs a result, Defendants' statements about ADMA Biologics' business, operations, and prospects were materially false
More news about: Hagens Berman Sobol Shapiro LLP
Jul 29, 2026, 10:09 ET Levi & Korsinsky Reminds ADMA BIOLOGICS, INC. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 10, 2026 - ADMA
among ISS Top 50 for seven consecutive years.Frequently Asked Questions About the ADMA LawsuitQ: Who is eligible to join the ADMA investor lawsuit? A: Investors who purchased ADMA stock or securities between August 9, 2024 and March 25, 2026 and suffered financial losses may
More news about: Levi & Korsinsky, LLP
Jul 28, 2026, 10:10 ET ADMA AUGUST 10, 2026 DEADLINE: ADMA Biologics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit- HBSS
844-916-0895Alleged Wrongdoing in ADMA Biologics Lawsuit: The lawsuit alleges that Defendants artificially inflated stock value by misrepresenting and failing to disclose that:ADMA Biologics engaged in an undisclosed related party transaction;ADMA Biologics used
More news about: Hagens Berman Sobol Shapiro LLP
Jul 28, 2026, 10:07 ET ADMA Shareholder Alert: ADMA Biologics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm
failed to disclose that: (1) ADMA Biologics engaged in an undisclosed related party transaction; (2) ADMA Biologics used channel stuffing to create an appearance of revenue; (3) ADMA Biologics lacked adequate internal controls; (4) as a result, defendants' statements about ADMA Biologics' business, operations,
More news about: The Gross Law Firm
Jul 28, 2026, 06:36 ET ADMA Class Reminder: ADMA Biologics Investors are Reminded of the Upcoming August 10 Deadline in the Filed Securities Fraud Class Action to Recover Losses
investors in ADMA securities. The class action is pending in the U.S. District Court for the District of New Jersey. It is captioned Mazzarino v. ADMA Biologics, Inc., et al., No. 26-cv-6918.Why is ADMA Biologics Being Sued for Securities Fraud? ADMA has been sued
More news about: Bleichmar Fonti & Auld LLP
Jul 28, 2026, 03:58 ET ADMA Biologics, Inc. Investor Alert: Contact SBS by August 10, 2026 for Opportunity to Lead Securities Fraud Lawsuit
action lawsuit against ADMA Biologics, Inc. ("ADMA" or "the Company") (NASDAQ: ADMA) for violations of §§10(b)
More news about: Schall, Brown & Schwartz LLP
Jul 27, 2026, 18:34 ET ADMA Deadline: ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
failed to disclose that: (1) ADMA Biologics engaged in an undisclosed related party transaction; (2) ADMA Biologics used channel stuffing to create an appearance of revenue; (3) ADMA Biologics lacked adequate internal controls; and (4) as a result, defendants' statements about ADMA Biologics' business, operations,
More news about: THE ROSEN LAW FIRM, P. A.
Jul 27, 2026, 09:30 ET ADMA Alert: ADMA Biologics, Inc. (NASDAQ: ADMA) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed
844-916-0895Alleged Wrongdoing in ADMA Biologics Lawsuit: The lawsuit alleges that Defendants artificially inflated stock value by misrepresenting and failing to disclose that:ADMA Biologics engaged in an undisclosed related party transaction;ADMA Biologics used
More news about: Hagens Berman Sobol Shapiro LLP
Jul 27, 2026, 04:40 ET ADMA Biologics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ADMA
action lawsuit against ADMA Biologics, Inc. ("ADMA" or "the Company") (NASDAQ: ADMA) for violations of
More news about: DJS Law Group LLP
Jul 24, 2026, 22:00 ET ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA
ADMA Biologics, Inc. (NasdaqGM: ADMA) ("ADMA" or the "Company"), if they purchased or otherwise acquired the Company's securities between August 9, 2024 and March 25, 2026,
More news about: ClaimsFiler
Jul 24, 2026, 08:00 ET ADMA INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- HBSS
844-916-0895Alleged Wrongdoing in ADMA Biologics Lawsuit: The lawsuit alleges that Defendants artificially inflated stock value by misrepresenting and failing to disclose that:ADMA Biologics engaged in an undisclosed related party transaction;ADMA Biologics used
More news about: Hagens Berman Sobol Shapiro LLP
Jul 23, 2026, 16:08 ET ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
investors with losses related to ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA) have opportunity to lead
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Jul 23, 2026, 10:09 ET Lost Money on ADMA BIOLOGICS, INC. (ADMA)? Join Class Action Suit Seeking Recovery - Contact SueWallSt
/PRNewswire/ -- SueWallSt highlights the contrast between ADMA Biologics, Inc.'s (NASDAQ: ADMA) public growth projections and the results alleged by independent research. A securities class action has been filed on behalf of investors who purchased ADMA securities between August 9, 2024 and March 25,
More news about: SueWallSt.com
Jul 23, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologics, Inc. of Class Action Lawsuit and Upcoming Deadlines - ADMA
July 23, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA). Such investors are advised to contact Danielle Peyton at [email protected]
More news about: Pomerantz LLP
Jul 23, 2026, 09:00 ET ADMA Alert: ADMA Biologics, Inc. (NASDAQ: ADMA) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed
844-916-0895Alleged Wrongdoing in ADMA Biologics Lawsuit: The lawsuit alleges that Defendants artificially inflated stock value by misrepresenting and failing to disclose that:ADMA Biologics engaged in an undisclosed related party transaction;ADMA Biologics used
More news about: Hagens Berman Sobol Shapiro LLP
Jul 23, 2026, 07:00 ET ADMA INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that ADMA Biologics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
lawsuit. Captioned Mazzarino v. ADMA Biologics, Inc., No. 26-cv-06918 (D.N.J.), the ADMA Biologics class action lawsuit charges ADMA Biologics and certain of ADMA Biologics' executive officers with violations of the Securities Exchange Act of 1934.
More news about: Robbins Geller Rudman & Dowd LLP
Jul 22, 2026, 18:33 ET ADMA Deadline: ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
failed to disclose that: (1) ADMA Biologics engaged in an undisclosed related party transaction; (2) ADMA Biologics used channel stuffing to create an appearance of revenue; (3) ADMA Biologics lacked adequate internal controls; and (4) as a result, defendants' statements about ADMA Biologics' business, operations,
More news about: THE ROSEN LAW FIRM, P. A.
Jul 22, 2026, 10:09 ET ADMA Deadline Alert: Levi & Korsinsky Reminds ADMA BIOLOGICS, INC. (ADMA) Investors of Securities Class Action Deadline on August 10, 2026
filed by August 10, 2026.Frequently Asked Questions About the ADMA LawsuitQ: What is the ADMA class action lawsuit about? A: A securities class action has been filed against ADMA Biologics, Inc. (NASDAQ: ADMA) alleging materially false and misleading statements between August 9,
More news about: Levi & Korsinsky, LLP
Jul 21, 2026, 12:00 ET ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
August 9, 2024 and March 25, 2026, Defendants failed to disclose to investors that: (1) ADMA engaged in an undisclosed related party transaction; (2) ADMA used channel stuffing to create an appearance of revenue; (3) ADMA lacked adequate internal controls; and (4) as a result, Defendants' positive statements
More news about: Law Offices of Howard G. Smith
Jul 21, 2026, 10:05 ET ADMA DEADLINE: The Gross Law Firm Reminds ADMA Biologics, Inc. Investors of Upcoming Securities Class Action Deadline
failed to disclose that: (1) ADMA Biologics engaged in an undisclosed related party transaction; (2) ADMA Biologics used channel stuffing to create an appearance of revenue; (3) ADMA Biologics lacked adequate internal controls; (4) as a result, defendants' statements about ADMA Biologics' business, operations,
More news about: The Gross Law Firm